Magic of Lucid targets rare and specialist diseases

Lucid Group, the award-winning global medical communications company with offices in London, Buckinghamshire, Macclesfield and New York, has announced the launch of a new agency specialising in rare and specialist diseases.

Vivid MedComms Limited, based in Loudwater Buckinghamshire, will be headed by Alison Cantle (Managing Director), who has over 20 years’ medical communications experience.

This move mirrors an industry-wide shift towards focusing on rare and specialist diseases, with revenues from orphan drugs outpacing sales of mainstream drugs for the last decade, a trend that’s expected to continue for the next 30 years. According to the Orphan Drug Report (2015), sales of orphan drugs will account for 20% of all prescription drug sales by 2020.

Alison commented, “Our business in rare diseases has increased threefold over the last year. Making the decision to create a new stand-alone company focused on this area is an obvious choice. We have developed a dedicated and talented team of account handlers and medical writers brimming with specific skills and experience related to developing excellent comms programmes in rare diseases. The team are excited by the challenge and looking forward to transforming the lives of both clients and teams in this space.”

If you would like to discuss medical education support from the Vivid team, please contact:

E: M: 07780 455605

Recent posts
We transform lives. Always. Get in touch to find out more.